Date: 22-Aug-2019

Sandoz receives regulatory approval from NMPA for Rosuvastatin

Sandoz has announced that it has received regulatory approval from Chinas National Medical Products Administration (NMPA) for its generic Rosuvastatin, under the NMPAs Quality Consistency Evaluation (QCE) system